| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.31 | 2e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 5e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |